Upload
jonas-marvin-anaque
View
216
Download
0
Embed Size (px)
Citation preview
7/25/2019 Pharma Ob and Nutrition
1/28
Oxytocin Dosage and Administration
Parenteral drug products should be inspected visually for particulate matter and
discoloration prior to administration, whenever solution and container permit.
Dosage of Oxytocin is determined by the uterine response. The following dosage
information is based upon various regimens and indications in general use.
A. Induction or Stimulation of Labor
Intravenous infusion (drip method) is the only acceptable method of administration for
the induction or stimulation of labor.
Accurate control of the rate of infusion flow is essential. An infusion pump or other suchdevice and frequent monitoring of strength of contractions and fetal heart rate are
necessary for the safe administration of Oxytocin for the induction or stimulation of
labor. If uterine contractions become too powerful, the infusion can be abruptly stopped,
and oxytocic stimulation of the uterine musculature will soon wane.
1. An intravenous infusion of nonOxytocin-containing solution should be started.
Physiologic electrolyte solution should be used except under unusual circumstances.
2. To prepare the usual solution for infusion, 1-mL Oxytocin Injection, 10 USP Units/mL
is combined aseptically with 1,000 mL of nonhydrating diluent (physiologic electrolytesolution). The combined solution, rotated in the infusion bottle to ensure thorough
mixing, containing 10 mU/mL. Add the container with dilute oxytocic solution to the
system through use of a constant infusion pump or other such device, to control
accurately the rate of infusion.
3. The initial dose should be no more than 1 to 2 mU/min. the dose may be gradually
increased in increments of no more than 1 to 2 mU/min. until a contraction pattern has
been established which is similar to normal labor.
4. The fetal heart rate, resting uterine tone, and the frequency, duration, and the force of
contractions should be monitored.5. The Oxytocin infusion should be discontinued immediately in the event of uterine
hyperactivity or fetal distress. Oxygen should be administered to the mother. The mother
and the fetus must be evaluated by the responsible physician.
B. Control of Postpartum Uterine Bleeding
7/25/2019 Pharma Ob and Nutrition
2/28
1. Intravenous Infusion (Drip Method):
To control postpartum bleeding, 10 to 40 units of Oxytocin may be added to 1,000 mL of
a nonhydrating diluent (physiologic electrolyte solution) and run a rate necessary to
control uterine atony.2. Intramuscular Administration:
1 mL (10 units) of Oxytocin can be given after the delivery of the placenta.
C. Treatment of Incomplete or Inevitable Abortion
Intravenous infusion with physiologic saline solution, 500 mL, or 5% dextrose in
physiologic saline solution to which 10 units of Oxytocin have been added should be
infused at a rate of 20 to 40 drops per minutes.
Generic Name: Methergine
Brand name:Methylergonovine Maleate
Pharmacologic:ergot alkaloids
Availability Tablets:200 mcg (0.2 mg).Injection:200 mcg (0.2 mg)/ml in 1-ml
ampules.
Action
Methylergonovine maleate(methergine) is an ergot alkaloid that stimulate smooth
muscle tissue.Because the smooth muscle of the uterus is especially sensitive to this
drug it is used postpartally to stimulate the uterus to contract in order to decrease
!lood loss !y clamping off uterine !lood vessels and to promote the involution
process ."n addition the drug has vasoconstrictive effect on all !lood vesselsespecially
the larger arteries.
Route,osage,!re"uency
Methergine has a rapid onset of action and may !e given orally or intramuscularly.
#sually IM dose: #$% mgfollo$ing e%pulsion of the placenta.&he dose may !erepeated every 2-' hours if necessary.
#sual oral dose: #$% mgevery ' hours (si% doses)
Maternal &ontraindications
regnancyhepatic or renal disease cardiac disease hypertension or preeclampsia
7/25/2019 Pharma Ob and Nutrition
3/28
contraindicate this drugs use.Methylergonovine maleate must !e used $ith caution
during lactation.
Maternal 'ide ())ects
ypertensionnauseavomitingheadache!randycardiadi**inesstinnitusa!dominal
crampspalpitationsdyspneachest pain and allergic reactions may !e noted.
Nursing Im*lications
Monitor fundal height and consistency and the amount and character of the
lochia.
+ssess the !lood pressure !efore and routinely throughout drug
administration.
,!serve for adverse effects or symptoms of ergot to%icity(ergotism) such as
nausea and vomitingheadachemuscle paincold or num! fingers and
toeschest pain and general $eakness.
Patient +!amily Teaching
"nstruct patient to take medication as directed do not skip or dou!le up on
missed doses. "f a dose is missed omit it and return to regular dose schedule.
+dvise patient that medication may cause menstrual-like cramps
aution patient to avoid smoking !ecause nicotine constricts !lood vessels.
"nstruct patient to notify health care professional if infection develops as this
may cause increased sensitivity to the medication.
Nursing ImplicationsAssessment & Drug Effects
Monitor vital signs (particularly BP) and uterine response during and afterparenteral administration of methylergonovine until partum period is
stabilized (about 12 h).
otify physician if BP suddenly increases or if there are fre!uent periods ofuterine rela"ation.
Patient & Family Education
#eport severe cramping for increased bleeding.
7/25/2019 Pharma Ob and Nutrition
4/28
#eport any of the follo$ing% &old or numb 'ngers or toes nausea or vomitingchest or muscle pain.
o not breast feed $hile ta*ing this drug.
Magnesium +ulfate rug +tudy
&lassi'cation% ,herapeutic% mineral and electrolyte
replacements-supplements. Pharmacologic% minerals-electrolytes
ndications
,reatment-prevention of hypomagnesemia. ,reatment of hypertension.
/nticonvulsant associated $ith severe eclampsia pre0eclampsia or acute nephritis.
nlabeled uses% Preterm labor. ,reatment of ,orsade de pointes. /dunctive
treatment for bronchodilation in moderate to severe acute asthma.
Mechanism of /ction3ssential for the activity of many enzymes. Plays an important role in
neurotransmission and muscular e"citability. ,herapeutic 34ects% #eplacement in
de'ciency states. #esolution of eclampsia.
&ontraindications-Precautions
&ontraindicated in%5ypermagnesemia6 5ypocalcemia6 /nuria6 5eart bloc*6 /ctive
labor or $ithin 2 hr of delivery (unless used for preterm labor). se &autiously
in% /ny degree of renal insu7ciency6 igitalized patients.
/dverse #eactions-+ide 34ects
http://nursecareplan.blogspot.com/2012/04/magnesium-sulfate-drug-study_2796.htmlhttp://nursecareplan.blogspot.com/2012/04/magnesium-sulfate-drug-study_2796.html7/25/2019 Pharma Ob and Nutrition
5/28
&+% dro$siness. #esp% decreased respiratory rate. &8% arrhythmias bradycardia
hypotension. 9% diarrhea.M+%muscle $ea*ness. erm% :ushing s$eating.
Metab% hypothermia.
#oute-osage
,reatment of e'ciency (e"pressed asmg of Magnesium)M 8 (/dults)% +evere de'ciency;
7/25/2019 Pharma Ob and Nutrition
6/28
iron supplement (Oral route,
Parenteral route)Uses For iron supplement
Iron is a mineral that the body needs to produce red blood cells. When the body does
not get enough iron, it cannot produce the number of normal red blood cells needed to
keep you in good health. This condition is called iron deficiency (iron shortage) or iron
deficiency anemia.
Although many people in the U.S. get enough iron from their diet, some must take
additional amounts to meet their needs. For example, iron is sometimes lost with slow or
small amounts of bleeding in the body that you would not be aware of and which can
only be detected by your doctor. Your doctor can determine if you have an iron
deficiency, what is causing the deficiency, and if an iron supplement is necessary.
Lack of iron may lead to unusual tiredness, shortness of breath, a decrease in physical
performance, and learning problems in children and adults, and may increase your
chance of getting an infection.
Some conditions may increase your need for iron. These include:
Bleeding problems
Burns
Hemodialysis
Intestinal diseases
Stomach problems
Stomach removal
Use of medicines to increase your red blood cell count
In addition, infants, especially those receiving breast milk or low-iron formulas, may
need additional iron.
7/25/2019 Pharma Ob and Nutrition
7/28
Increased need for iron supplements should be determined by your health care
professional.
Injectable iron is administered only by or under the supervision of your health care
professional. Other forms of iron are available without a prescription; however, yourhealth care professional may have special instructions on the proper use and dose for
your condition.
Importance of Diet
For good health, it is important that you eat a balanced and varied diet. Follow carefully
any diet program your health care professional may recommend. For your specific
dietary vitamin and/or mineral needs, ask your health care professional for a list of
appropriate foods. If you think that you are not getting enough vitamins and/or mineralsin your diet, you may choose to take a dietary supplement.
Iron is found in the diet in two formsheme iron, which is well absorbed, and nonheme
iron, which is poorly absorbed. The best dietary source of absorbable (heme) iron is
lean red meat. Chicken, turkey, and fish are also sources of iron, but they contain less
than red meat. Cereals, beans, and some vegetables contain poorly absorbed
(nonheme) iron. Foods rich in vitamin C (e.g., citrus fruits and fresh vegetables), eaten
with small amounts of heme iron-containing foods, such as meat, may increase the
amount of nonheme iron absorbed from cereals, beans, and other vegetables. Somefoods (e.g., milk, eggs, spinach, fiber-containing, coffee, tea) may decrease the amount
of nonheme iron absorbed from foods. Additional iron may be added to food from
cooking in iron pots.
The daily amount of iron needed is defined in several different ways.
For U.S.
Recommended Dietary Allowances (RDAs) are the amount of vitamins and minerals
needed to provide for adequate nutrition in most healthy persons. RDAs for a given nutrientmay vary depending on a person's age, sex, and physical condition (e.g., pregnancy).
Daily Values (DVs) are used on food and dietary supplement labels to indicate the
percent of the recommended daily amount of each nutrient that a serving provides. DV
replaces the previous designation of United States Recommended Daily Allowances
(USRDAs).
7/25/2019 Pharma Ob and Nutrition
8/28
For Canada
Recommended Nutrient Intakes (RNIs) are used to determine the amounts of vitamins,
minerals, and protein needed to provide adequate nutrition and lessen the risk of chronic
disease.
Normal daily recommended intakes in milligrams (mg) for iron are generally defined as
follows (Note that the RDA and RNI are expressed as an actual amount of iron, which is
referred to as elemental' iron. The product form [e.g., ferrous fumarate, ferrous
gluconate, ferrous sulfate] has a different strength):
Persons U.S.
(mg)
Canada
(mg)
Infants birth to 3 years of age 610 0.36
Children 4 to 6 years of age 10 8
Children 7 to 10 years of age 10 810
Adolescent and adult males 10 810
Adolescent and adult females 1015 813
Pregnant females 30 1722
Breast-feeding females 15 813
Before Using iron supplement
If you are taking a dietary supplement without a prescription, carefully read and follow
any precautions on the label. For these supplements, the following should be
considered:
Allergies
Tell your doctor if you have ever had any unusual or allergic reaction to medicines in this
group or any other medicines. Also tell your health care professional if you have any
other types of allergies, such as to foods dyes, preservatives, or animals. For non-
prescription products, read the label or package ingredients carefully.
7/25/2019 Pharma Ob and Nutrition
9/28
Pediatric
Problems in children have not been reported with intake of normal daily recommended
amounts. Iron supplements, when prescribed by your health care professional, are not
expected to cause different side effects in children than they do in adults. However, it isimportant to follow the directions carefully, since iron overdose in children is especially
dangerous.
Studies on sodium ferric gluconate have shown that this supplement is safe to use in
children ages 6 to 15 years. The safety of sodium ferric gluconate has not been
determined in patients who are younger than 6 years of age.
Geriatric
Problems in older adults have not been reported with intake of normal daily
recommended amounts. Elderly people sometimes do not absorb iron as easily as
younger adults and may need a larger dose. If you think you need to take an iron
supplement, check with your health care professional first. Only your health care
professional can decide if you need an iron supplement and how much you should take.
Pregnancy
It is especially important that you are receiving enough vitamins and minerals when you
become pregnant and that you continue to receive the right amount of vitamins and
minerals throughout your pregnancy. Healthy fetal growth and development depend on a
steady supply of nutrients from mother to fetus. During the first 3 months of pregnancy,
a proper diet usually provides enough iron. However, during the last 6 months, in order
to meet the increased needs of the developing baby, an iron supplement may be
recommended by your health care professional.
However, taking large amounts of a dietary supplement in pregnancy may be harmful to
the mother and/or fetus and should be avoided.
Breast Feeding
It is especially important that you receive the right amounts of vitamins and minerals so
that your baby will also get the vitamins and minerals needed to grow properly. Iron
normally is present in breast milk in small amounts. When prescribed by a health care
7/25/2019 Pharma Ob and Nutrition
10/28
professional, iron preparations are not known to cause problems during breast-feeding.
However, nursing mothers are advised to check with their health care professional
before taking iron supplements or any other medication. Taking large amounts of a
dietary supplement while breast-feeding may be harmful to the mother and/or infant and
should be avoided.
Interactions with Medicines
Although certain medicines should not be used together at all, in other cases two
different medicines may be used together even if an interaction might occur. In these
cases, your doctor may want to change the dose, or other precautions may be
necessary. When you are taking any of these dietary supplements, it is especially
important that your healthcare professional know if you are taking any of the medicines
listed below. The following interactions have been selected on the basis of their potentialsignificance and are not necessarily all-inclusive.
Using dietary supplements in this class with any of the following medicines is usually not
recommended, but may be required in some cases. If both medicines are prescribed
together, your doctor may change the dose or how often you use one or both of the
medicines.
Altretamine
Amygdalin
Dabrafenib
Dasabuvir
Deferoxamine
Digoxin
Eltrombopag
Elvitegravir
Ketoconazole
Ledipasvir
Paritaprevir
Pazopanib
7/25/2019 Pharma Ob and Nutrition
11/28
Phenytoin
Rilpivirine
Vismodegib
Interactions with Food/Tobacco/Alcohol
Certain medicines should not be used at or around the time of eating food or eating
certain types of food since interactions may occur. Using alcohol or tobacco with certain
medicines may also cause interactions to occur. Discuss with your healthcare
professional the use of your medicine with food, alcohol, or tobacco.
Other Medical Problems
The presence of other medical problems may affect the use of dietary supplements in
this class. Make sure you tell your doctor if you have any other medical problems,
especially:
Alcohol abuse (or history of) or
Blood transfusions (with high red blood cell iron content) or
Kidney infection or
Liver disease or
Porphyria cutaneous tardaHigher blood levels of the iron supplement may occur, which
may increase the chance of side effects.
Arthritis (rheumatoid) or
Asthma or allergies or
Heart diseaseThe injected form of iron may make these conditions worse.
Colitis or other intestinal problems or
Iron overload conditions (e.g., hemochromatosis, hemosiderosis, hemoglobinopathies)or
Stomach ulcerIron supplements may make these conditions worse.
Other anemiasIron supplements may increase iron to toxic levels in anemias not
associated with iron deficiency.
7/25/2019 Pharma Ob and Nutrition
12/28
Proper Use of iron supplement
After you start using this dietary supplement, continue to return to your health care
professional to see if you are benefiting from the iron. Some blood tests may be
necessary for this.
Iron is best absorbed when taken on an empty stomach, with water or fruit juice (adults:
full glass or 8 ounces; children: glass or 4 ounces), about 1 hour before or 2 hours
after meals. However, to lessen the possibility of stomach upset, iron may be taken with
food or immediately after meals.
For safe and effective use of iron supplements:
Follow your health care professional's instructions if this dietary supplement was
prescribed.
Follow the manufacturer's package directions if you are treating yourself. If you think you
still need iron after taking it for 1 or 2 months, check with your health care professional.
Liquid forms of iron supplementtend to stain the teeth. To prevent, reduce, or remove
these stains:
Mix each dose in water, fruit juice, or tomato juice. You may use a drinking tube or straw
to help keep the iron supplement from getting on the teeth.
When doses of liquid iron supplement are to be given by dropper, the dose may be
placed well back on the tongue and followed with water or juice.
Iron stains on teeth can usually be removed by brushing with baking soda (sodium
bicarbonate) or medicinal peroxide (hydrogen peroxide 3%).
Dosing
The dose medicines in this class will be different for different patients. Follow your
doctor's orders or the directions on the label. The following information includes only the
average doses of these medicines. If your dose is different, do not change it unless your
doctor tells you to do so.
The amount of medicine that you take depends on the strength of the medicine. Also,
the number of doses you take each day, the time allowed between doses, and the length
7/25/2019 Pharma Ob and Nutrition
13/28
of time you take the medicine depend on the medical problem for which you are using
the medicine.
For oral dosage forms (capsules, tablets, oral solution):
o To prevent deficiency, the amount taken by mouth is based on normal daily
recommended intakes:
For the U.S.
o Adult and teenage males10 milligrams (mg) per day.
o Adult and teenage females10 to 15 mg per day.
o Pregnant females30 mg per day.
o Breast-feeding females15 mg per day.
o Children 7 to 10 years of age10 mg per day.
o Children 4 to 6 years of age10 mg per day.
o Children birth to 3 years of age6 to 10 mg per day.
o For Canada
o Adult and teenage males8 to 10 mg per day.
o Adult and teenage females8 to 13 mg per day.
o Pregnant females17 to 22 mg per day.
o Breast-feeding females8 to 13 mg per day.
o Children 7 to 10 years of age8 to 10 mg per day.
o Children 4 to 6 years of age8 mg per day.
o Children birth to 3 years of age0.3 to 6 mg per day.
2 To treat deficiency:
o Adults, teenagers, and children The dose will be determined by your
doctor, based on your condition.
2 For injection dosage forms:
1 Adults, teenagers, and children The dose will be determined by your doctor, based on
your condition.
7/25/2019 Pharma Ob and Nutrition
14/28
Missed Dose
If you miss a dose of iron supplement, skip the missed dose and go back to your regular
dosing schedule. Do not double doses.
Storage
Keep out of the reach of children.
Store the medicine in a closed container at room temperature, away from heat,
moisture, and direct light. Keep from freezing.
Do not keep outdated medicine or medicine no longer needed.
Precautions While Using iron supplement
When iron is combined with certain foods it may lose much of its value. If you are taking
iron, the following foods should be avoided, or only taken in very small amounts, for at
least 1 hour before or 2 hours after you take iron:
Cheese and yogurt
Eggs
Milk
Spinach
Tea or coffee
Whole-grain breads and cereals and bran
Do not take iron supplements and antacids or calcium supplements at the same time. It
is best to space doses of these 2 products 1 to 2 hours apart, to get the full benefit from
each medicine or dietary supplement.
If you are taking iron supplementswithout a prescription:
Do not take iron supplements by mouth if you are receiving iron injections. To do so may
result in iron poisoning.
7/25/2019 Pharma Ob and Nutrition
15/28
Do not regularly take large amounts of iron for longer than 6 months without checking
with your health care professional. People differ in their need for iron, and those with certain
medical conditions can gradually become poisoned by taking too much iron over a period of
time. Also, unabsorbed iron can mask the presence of blood in the stool, which may delay
discovery of a serious condition.
If you have been taking a long-acting or coated iron tablet and your stools
havenotbecome black, check with your health care professional. The tablets may not
be breaking down properly in your stomach, and you may not be receiving enough iron.
It is important to keep iron preparations out of the reach of children. Keep a 1-ounce
bottle ofsyrupof ipecac available at home to be taken in case of an iron overdose
emergency when a doctor, poison control center, or emergency room orders its use.
If you think you or anyone else has taken an overdose of iron medicine:
Call your doctor, a poison control center, or the nearest hospital emergency room at
once. Always keep these phone numbers readily available.
Follow any instructions given to you. If syrup of ipecac has been ordered and given, do
not delay going to the emergency room while waiting for the ipecac syrup to empty the
stomach, since it may require 20 to 30 minutes to show results
Go to the emergency room without delay
Take the container of iron with you.
Early signs of iron overdose may not appear for up to 60 minutes or more. Do not delay
going to the emergency room while waiting for signs to appear.
iron supplement Side Effects
Along with its needed effects, a medicine may cause some unwanted effects. Although
not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor as soon as possible if any of the following side effects occur:
More common-with injection only
Backache , groin, side, or muscle pain
7/25/2019 Pharma Ob and Nutrition
16/28
chest pain
chills
dizziness
fainting
fast heartbeat
fever with increased sweating
flushing
headache
metallic taste
nausea or vomiting
numbness, pain, or tingling of hands or feet
pain or redness at injection site
redness of skin
skin rash or hives
swelling of mouth or throat
troubled breathing
More common-when taken by mouth only
Abdominal or stomach pain
cramping (continuing) or soreness
Less common or rare-with injection only
Double vision
general unwell feeling
weakness without feeling dizzy or faint
Less common or rare-when taken by mouth only
Chest or throat pain, especially when swallowing
stools with signs of blood (red or black color)
Early symptoms of iron overdose
7/25/2019 Pharma Ob and Nutrition
17/28
Symptoms of iron overdose may not occur for up to 60 minutes or more after the
overdose was taken. By this time you should have had emergency room treatment. Do
not delay going to emergency room while waiting for signs to appear.
Diarrhea (may contain blood)
fever
nausea
stomach pain or cramping (sharp)
vomiting, severe (may contain blood)
Late symptoms of iron overdose
Bluish-colored lips, fingernails, and palms of hands
convulsions (seizures)
pale, clammy skin
shallow and rapid breathing
unusual tiredness or weakness
weak and fast heartbeat
Some side effects may occur that usually do not need medical attention. These side
effects may go away during treatment as your body adjusts to the medicine. Also, your
health care professional may be able to tell you about ways to prevent or reduce some
of these side effects. Check with your health care professional if any of the following
side effects continue or are bothersome or if you have any questions about them:
More common
Constipation
diarrhea
leg cramps
nausea
vomiting
Less common
7/25/2019 Pharma Ob and Nutrition
18/28
Stools commonly become dark green or black when iron preparations are taken by
mouth. This is caused by unabsorbed iron and is harmless. However, in rare cases,
black stools of a sticky consistency may occur along with other side effects such as red
streaks in the stool, cramping, soreness, or sharp pains in the stomach or abdominal
area. Check with your health care professional immediately if these side effects appear.
If you have been receiving injections of iron, you may notice a brown discoloration of
your skin. This color usually fades within several weeks or months.
Darkened urine
heartburn
stained teeth
Other side effects not listed may also occur in some patients. If you notice any other
effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the
FDA at 1-800-FDA-1088.
AdministrationOral
9ive on an empty stomach if possible because oral iron preparations are bestabsorbed then (i.e. bet$een meals). Minimize gastric distress if needed bygiving $ith or immediately after meals $ith ade!uate li!uid.
o not crush tablet or empty contents of capsule $hen administering.
o not give tablets or capsules $ithin 1 h of bedtime.
&onsult physician about prescribing a li!uid formulation or a less corrosiveform such as ferrous gluconate if the patient e"periences di7culty in
s$allo$ing tablet or capsule.
ilute li!uid preparations $ell and give through a stra$ or placed on the bac*of tongue $ith a dropper to prevent staining of teeth and to mas* taste.nstruct the patient to rinse mouth $ith clear $ater immediately afteringestion.
7/25/2019 Pharma Ob and Nutrition
19/28
Mi" ferosol eli"ir $ith $ater6 not compatible $ith mil* or fruit uice. Cer0n0+ol(drops) may be given in $ater or in fruit or vegetable uice according tomanufacturer.
o not use discolored tablets.
+tore in tightly closed containers and protect from moisture. +tore at 1?D@D& (?ED
7/25/2019 Pharma Ob and Nutrition
20/28
7/25/2019 Pharma Ob and Nutrition
21/28
:. e;uest prescri!ed !lood/!lood components from !lood !ank to include !lood
typing and cross matching and !lood result of transmissi!le 5isease.
. ave a doctor and a nurse assess patients condition. ountercheck the
compati!le !lood to !e transfused against the crossmatching sheet noting the
+B, grouping and serial num!er of each !lood unit and e%piry date $ith
the !lood !ag la!el and other la!oratory !lood e%ams as re;uired !efore
transfusion.
7. 4et the !aseline vital signs- B and &emperature !efore transfusion.
efer to M5 accordingly.
10.4ive pre-meds 0 minutes !efore transfusion as prescri!ed.
11.5o hand hygiene !efore and after the procedure12.repare e;uipment needed for B& (" in?ection tray compati!le B& set "
catheter/ needle 4 17/17 plaster torni;uet !lood !lood components to !e
transfused lain 899 :00cc " set needle gauge 1> (only if needed) "
hook gloves sterile 2@2 gau*e or transplant dressing etc.
1."f main "f is $ith de%trose :A initiate an " line $ith appropriate " catheter
$ith lain 899 on another site anchor catheter properly and regulate "
drops.
1'.,pen compati!le !lood set aseptically and close the roller clamp. 9pike !lood
!ag carefully fill the drip cham!er at least half full prime tu!ing and remove
air !u!!les (if any). #se needle g.1> or 17 for side drip (for adults) or g.22 for
pedia (if !lood is given to the -in?ection port the gauge of the needle is
disregarded).
1:.5isinfect the -in?ection port of " tu!ing (lain 899) and insert the needle
from B& administration ser and secure $ith adhesive tape.
1
7/25/2019 Pharma Ob and Nutrition
22/28
open the " line $ith lain 899 and regulate accordingly and report to the
doctor immediately.
17.9$irl the !ag gently from time to time to mi% the solid $ith the plasma 8.B
one B.& set should !e used for 1-2 units of !lood.
20.=hen !lood is consumed close the roller clamp of B& and disconnect from "
lines then regulate the "D of plain 899 as prescri!ed.
21.ontinue to o!serve and monitor patient post transfusion for delayed reaction
could still occur.
22.e-check g! and ct !leeding time serial platelet count $ithin specified
hours as prescri!ed and/or per institutions policy.
2.5iscard !lood !ag and B& set and sharps according to ealth are =aste
Management (5,/538).
2'.Dill-out adverse reaction sheet as per institutional policy.2:.emind the doctor a!out the administration of alcium 4luconate if patient
has several units of !lood transfusion (-: more units of !lood).
Blood administration
Patient preparation
Pretransfusion check
Blood Transfusion Record
Transfusion Tag
Care and monitoring of transfused patients
BLOOD PRODUCT ADMII!TRATIO "PD#$poster
PLAT%L%T ADMII!TRATIO "PD#$Posters
ursing Competence
It is recommended that all nurses at RC& pro'iding care to children recei'ing (lood transfusions ha'e
completed the (lood transfusion competenc) package* +ou can access the package through )our
ursing Competence ,ork(ook*
http://www.rch.org.au/bloodtrans/blood_administration/Blood_administration/#Patient_Preparationhttp://www.rch.org.au/bloodtrans/blood_administration/Blood_administration/#Pretransfusion_checkhttp://www.rch.org.au/bloodtrans/blood_administration/Blood_administration/#Blood_Transfusion_Recordhttp://www.rch.org.au/bloodtrans/blood_administration/Blood_administration/#Transfusion_Taghttp://www.rch.org.au/bloodtrans/blood_administration/Blood_administration/#Care_and_monitoringhttp://www.rch.org.au/uploadedFiles/Main/Content/bloodtrans/BLOOD_PRODUCT_ADMINISTRATION.pdfhttp://www.rch.org.au/uploadedFiles/Main/Content/bloodtrans/PLATELET_ADMINISTRATION.pdfhttp://www.rch.org.au/uploadedFiles/Main/Content/bloodtrans/PLATELET_ADMINISTRATION.pdfhttp://www.rch.org.au/bloodtrans/blood_administration/Blood_administration/#Patient_Preparationhttp://www.rch.org.au/bloodtrans/blood_administration/Blood_administration/#Pretransfusion_checkhttp://www.rch.org.au/bloodtrans/blood_administration/Blood_administration/#Blood_Transfusion_Recordhttp://www.rch.org.au/bloodtrans/blood_administration/Blood_administration/#Transfusion_Taghttp://www.rch.org.au/bloodtrans/blood_administration/Blood_administration/#Care_and_monitoringhttp://www.rch.org.au/uploadedFiles/Main/Content/bloodtrans/BLOOD_PRODUCT_ADMINISTRATION.pdfhttp://www.rch.org.au/uploadedFiles/Main/Content/bloodtrans/BLOOD_PRODUCT_ADMINISTRATION.pdfhttp://www.rch.org.au/uploadedFiles/Main/Content/bloodtrans/PLATELET_ADMINISTRATION.pdfhttp://www.rch.org.au/uploadedFiles/Main/Content/bloodtrans/PLATELET_ADMINISTRATION.pdf7/25/2019 Pharma Ob and Nutrition
23/28
Patient Preparation
The patient should (e read) for transfusion prior to picking up (lood from the (lood (ank* eg appropriate
I- access. ,ritten order for transfusion*
#or an) non/emergenc) transfusion the patient0parents should ha'e had the (enefits0risks of transfusion
discussed and an opportunit) to ha'e an) 1uestions ans,ered* Consent for transfusion should then (e
documeted in the medical record*
#or further information and for parent and patient information packs see2 Consent and Consumer
Information 3uideline
Pretransfusion check
+ae transusion re,uires a -nal patient identit. chec* at the patientedside eore lood administration' "his is vital to ensure the right lood
is given to the right patient'
The pretransfusion check must (e completed (efore commencing transfusion () t,o clinical staff. one of
,hom must then spike and connect the product* The staff mem(ers signing the (lood transfusion record
are indicating that the check has (een completed prior to transfusion. and that no discrepanc) ,as
identified*
The follo,ing checks are carried out at the (edside to ensure the right patient recei'es the right (lood
product2
4* Check (lood product for an) signs of leakage. clumps or a(normal colour*
5* Patient identification* Check name. DOB and UR on the Blood Transfusion Record and
pack tag0la(el* Check name. DOB 6 UR on the patient7s ,rist(and* Are the) identical8
9* Blood product identification* Check the pack num(er on the Blood Transfusion Record.
pack tag0la(el and the product* Are the) identical8
:* Blood 3roup* Check the (lood group "ABO and RhD$ of the product on the Blood
Transfusion Record "this form reports compati(ilit)$. pack tag0la(el and the product* Do the)
match8
;* Check e
7/25/2019 Pharma Ob and Nutrition
24/28
=* Check medical orders re product t)pe. special re1uirements "eg irradiation. leucoc)te
depletion$ and administration re1uirements "eg 'olume. rate$*
>* Complete documentation2 sign. date. time the Blood Transfusion Record and file in the
patient7s medical record*
IMP!"A#"
If there is an) discrepanc) (et,een the (lood product. patient details 6 pack tag0la(el or if )ou
are concerned a(out the appearance of the product D #" "!A#SF$SE* Report to Blood Bank
immediatel)2 RC& ?n ;@5. R& ?n 5;;*
Blood "ransfusion !ecord
A Blood Transfusion Record "MR054$ accompanies the release of fresh (lood products*
7/25/2019 Pharma Ob and Nutrition
25/28
"he /lood "ransusion 0ecord is a legal document and must e -led in the
patient medical record at the completion o transusion' "he record must
e availale or at least 2 .ears'
"ransfusion "ag
A tag is attached to each (lood product*
%are and monitoring of transfused patients
Patients receiving transfusion should be monitored for symptoms/signs of potential
complications of transfusion.
"he !o&al 'omen(s )ospital
#re1uenc) of 'ital signs2
Adults/ temperature. pulse. respirator) rate and (lood pressure should (e measured and recorded2
7/25/2019 Pharma Ob and Nutrition
26/28
(efore the start of each pack of (lood or (lood product
at 4; minutes after commencement
hourl) during transfusion
at the completion of each pack
#eonates/ temperature. heart rate and respirator) rate should (e measured and recorded2
(efore the start of each pack of (lood or (lood product
hourl) during transfusion
at the completion of each pack
ote that more fre1uent 'ital signs should (e taken if the patient has an unsta(le underl)ing condition or itthe patient (ecomes un,ell or sho,s signs of a transfusion reaction*
Patients should (e o(ser'ed during the first 4; minutes of transfusion as some life/threatening reactions
ma) occur after the infusion of onl) a small amount of (lood* here possi(le. patients should (e informed
of possi(le s)mptoms of a transfusion reaction and should inform staff immediatel) if the) feel un,ell
during transfusion*
!o&al %hildren(s )ospital
-ital signs "temperature. pulse. respirations. (lood pressure. o
7/25/2019 Pharma Ob and Nutrition
27/28
Preterm la(or is defined as uterine contractions occurring after 5 ,eeks of
gestation and (efore 9> completed ,eeks of gestation* Risk factors
include multiple gestation, history of previous preterm labor of
delivery, abdominal surgery during current pregnancy,
uterine anomaly, history of cone biopsy, maternal age younger than
20 or older than age 35.
CLIICAL MAI#%!TATIO!
1. Go$ bac* pain
2. +uprapubic pressure. 8aginal presure
>. #hythmic uterine contrations
?. &ervical dilation and e4acement
=. Possible rupture of membranes
J. 3"pulsion of the cervical mucus plug
7/25/2019 Pharma Ob and Nutrition
28/28
Prepare for possible ultrasonography amniocentesis
tocolytic drug therapy and steroid theraphy
/dminister tocolytic (contraction0inhibiting) medications
as prescribed. /ssess for side e4ects of tocolytic therapy (eg decreased
maternal blood pressure dyspnea chest pain and C5#
e"ceeding 1 Provide physical and emotional support. Provide ade!uate
hydration
? Provide client and family education